Early Pregnancy Termination Options: Medication Abortion and Procedural Abortion

Medication Abortion (Mifepristone + Misoprostol)

  • Gestational limit: FDA-approved ≤70 days (10 weeks); evidence supports up to 11–12 weeks.
  • Regimen: Mifepristone 200 mg PO → 24–48 h later Misoprostol 800 mcg buccal/vaginal.
  • Efficacy: 95–98% complete expulsion; <1% need aspiration.
  • Process: Cramping, bleeding (heavier than period) 4–24 h post-misoprostol; tissue passage over hours–days.
  • Follow-up: hCG decline or ultrasound at 1–2 weeks.

Procedural (Aspiration) Abortion

  • Gestational limit: Up to 14–16 weeks (varies by clinic/state).
  • Procedure: Cervical preparation (osmotic dilators ± misoprostol) → vacuum aspiration (5–10 min) under local ± sedation.
  • Efficacy: >99% complete in one visit.
  • Recovery: Same-day discharge; cramping/spotting few days.

Safety Profile

  • Major complication rate: <0.3% (both methods).
  • Mortality: 0.4–0.7 per 100,000 (safer than childbirth 17/100,000).
  • No long-term fertility, mental health, or breast cancer risk.

Access Considerations

  • State laws vary (gestational bans, waiting periods, telehealth restrictions).
  • Telehealth medication abortion available in many states (mail-order mifepristone/misoprostol).
  • Financial aid: abortion funds, clinic sliding scale.

Decision Support

All-Options Talkline (1-888-493-0092), Planned Parenthood, NAF hotline—nonjudgmental, confidential counseling.

Pregnancy & Health - Related Articles